Charles Schwab Investment Management Inc Seagen Inc. Transaction History

Charles Schwab Investment Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$191.51 - $216.16 $1.79 Million - $2.02 Million	9,323 Added 1.87%	507,042 $108 Million
Q2 2023 Aug 09, 2023	BUY	$187.64 - $206.25 $2.12 Million - $2.34 Million	11,323 Added 2.33%	497,719 $95.8 Million
Q1 2023 May 11, 2023	BUY	$127.59 - $203.08 $939,189 - $1.49 Million	7,361 Added 1.54%	486,396 $98.5 Million
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $2.91 Million - $3.46 Million	24,829 Added 5.47%	479,035 $61.6 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $2.5 Million - $3.33 Million	18,462 Added 4.24%	454,206 $62.1 Million

Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $1.37 Million - $2.26 Million	12,588 Added 2.97%	435,744 $77.1 Million
Q1 2022 May 13, 2022	BUY	$119.61 - $157.85 $2.18 Million - $2.88 Million	18,248 Added 4.51%	423,156 $61 Million
Q4 2021 Feb 11, 2022	BUY	$142.57 - $190.86 $1.42 Million - $1.89 Million	9,926 Added 2.51%	404,908 $62.6 Million
Q3 2021 Nov 16, 2021	BUY	$142.45 - $169.82 $3.4 Million - $4.05 Million	23,855 Added 6.43%	394,982 $67.1 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $553,287 - $659,865	4,096 Added 1.12%	371,127 $58.6 Million
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $5.7 Million - $7.91 Million	-41,451 Reduced 10.15%	367,031 $51 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $67.2 Million - $86.6 Million	408,482 New	408,482 $71.5 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.